BSE filing, NSE: IPPL. Summary written from the filing by ALFA Finder's alert engine.
Kotia Enterprises Ltd: key numbers
- Share price
- ₹21.15
- Market cap
- ₹14.85 Cr
- Revenue (annual)
- ₹1.31 Cr
- Net profit (annual)
- ₹-2.50 Cr
- P/E (TTM)
- -6.2×Sector 32.4×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kotia Enterprises Ltd
All →Kotia Enterprises Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulation 31.
Kotia Enterprises Other Announcement
Kotia Enterprises Limited has re-appointed M/s. Ajay Rattan & Co. as Statutory Auditors for a five-year term. The appointment is effective from April 1, 2026.
- Execution
- 60 months
Kotia Enterprises Annual General Meeting
Kotia Enterprises Limited concluded its 46th Annual General Meeting where shareholders approved the FY2025-26 audited financial statements. The reappointment of Director Vikas Bansal and statutory auditors was also confirmed.
Kotia Enterprises Annual General Meeting
Kotia Enterprises Limited has fixed 22nd September 2026 as the record date for determining shareholder eligibility for its 46th Annual General Meeting.
Kotia Enterprises Annual Report
Kotia Enterprises Limited has submitted its Annual Report for the financial year 2025-26, along with the notice for the 46th Annual General Meeting.
Kotia Enterprises Annual General Meeting
Kotia Enterprises Ltd has scheduled its 46th Annual General Meeting for September 29, 2026. Shareholders may cast their votes via remote e-voting.
Other board meeting date announcements
All →HCP Plastene Bulkpack Board Meeting Date
HCP Plastene Bulkpack scheduled a board meeting for 06 November 2026. It will consider unaudited results for the quarter and half year ending 30 September 2026.
Ultracab (India) Board Meeting Date
Ultracab (India) Ltd intimated that its Board meeting is scheduled for 04-Nov-2026 to consider unaudited standalone financial results. No results or financial figures are disclosed in this advance notice.
Texmaco Infrastructure & Holdings Board Meeting Date
Texmaco has scheduled a Board meeting on November 5, 2026, to approve Q2 and H2 FY27 financial results. Trading window stays closed for insiders pending results declaration.
Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.
Mafatlal Industries Board Meeting Date
Mafatlal Industries updated that its 4 November 2026 board meeting will consider an interim dividend for FY27. Record date, if approved, is 13 November 2026.